5-Aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells

Gut

Volumn 44, Issue 2, 1999, Pages 180-185

  McKenzie, S M ^a   Doe, W F ^a   Buffinton, G D ^b,c  

^a Biology and Environment   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

5 aminosalicylic acid; 6 mercaptopurine; Glyceraldehyde 3 phosphate dehydrogenase; Metronidazole; Oxidants; Prednisolone

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESALAZINE; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; COLON MUCOSA; ENTERITIS; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033025312     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.2.180     Document Type: Article

References (38)

1. Babbs CF. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 1992;13:169-81.
2. McKenzie SJ, Baker MS, Buffinton GD, et al. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996;98:136-41.
3. Buffinton GD, Doe WF. Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients. Free Radic Res 1995;22:131-43.
4. Buffinton GD, Doe WF. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic Biol Med 1995;19:911-918.
5. Emerit J, Pelletier S, Likforman J, et al. Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in treatment of Crohn's disease. Free Radic Res Commun 1991;12-13: 563-9.
6. Niwa Y, Somiya K, Michelson AM, et al. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study. Free Radic Res Commun 1985;1:137-53.
7. von Ritter C, Grisham MB, Hollwarth M, et al. Neutrophil- derived oxidants mediate formyl-methionyl-leucylphenylalanine-induced increases in mucosal permeability in rats. Gastroenterology 1989;97:778-80.
8. Keshavarzian A, Morgan G, Sedghi S, et al. Role of reactive oxygen metabolites in experimental colitis. Gut 1090;31: 786-90.
9. Williams JG, Hallett MB. The reaction of 5-aminosalicylic acid with hypochlorite. Implications for its mode of action in inflammatory bowel disease. Bioehem Pharmacol 1989; 38:149-54.
10. Tamai H, Kachur JF, Grisham MB, et al. Scaverging effect of 5-aminosalicylic acid on neutrohil-derived oxidants: possible contribution to the mechanism of action in inflammatory bowel disease. Biochem Pharmacol 1991;41:1001-6.
11. Carlin G, Djursater R, Smedegard G, et al. Effect of anti-inflammatory drugs on xanthine oxidase and xanthine oxidase induced depolymerization of hyaluronic acid. Agents Actions 1985;16:377-84.
12. Miyachi Y, Yoshioka A, Imamura S, et al. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species. Gut 1987;28:190-5.
13. Aruoma OI, Wasil M, Halliwell B, et al. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects? Biochem Pharmacol 1987;36:3739-42.
14. Yamada T, Volkmer C, Grisham MB. The effects of sulfasalazine metabolites on hemoglobin-catalyzed lipid peroxidation. Free Radic Biol Med 1991;10:41-9.
15. Dull BJ, Salata K, Van Langenhove A, et al. 5-Aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage. Biochem Pharmacol 1987;36:2467-72.
16. Laffafian I, Brown RC, Hallett MB. The production of an amine-modified derivative of 5-aminosalicylic acid by activated neutrophils. Roles for myeloperoxidase and chloride ions. Biochem Pharmacol 1991;42:1869-74.
17. Campieri M, Lanfranchi GA, Bertoni E, et al. A double- blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis. Digestion 1984;29:204-8.
18. Jensen J, Cornett C, Olsen CE, et al. Identification of oxidation products of 5-aminosalicylic acid in faeces and the study of their formation in vitro. Biochem Pharmacol 1993; 45:1201-9.
19. Ahnfelt-Rønne I, Nielsen OH, Chrisensin A, et al. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterologv 1990;98:1162-9.
20. Lauterburg BH, Bilzer M, Rowedder E, et al. Decreased glutathione in inflamed colonic mucosa in man. Possible role of hypochlorous acid and prevention by 5-aminosalicylic acid. In: MacDermott RP, ed. Inflammatory bowel disease: current status and future approach. Amsterdam: Elsevier Science Publishers, 1988:273-6.
21. Blackburn AC, Buffinton GD, Doe WF. Colonic antioxidant status in dextran sulfate-induced colitis in mice. Inflammatory Bowel Disease 1997;3:198-203.
22. Beutler E. Glyceraldehyde phosphate dehydrogenase (GAPDH). In: Red cell metabolism: a manual of biochemical methods. 3rd edn. Orlando, FL: Grune and Stratton, Inc, 1984:55-6.
23. Blackburn A, Doe W, Buffinton G. Salicylate hydroxylation as an indicator of hydroxyl radical generation in dextran sulfate-induced colitis. Free Radic Biol Med 1998;25:305 13.
24. Wozniak A, Sharma DP, van de Pol E, et al. Depletion of neutrophils decreases disease severity and mortalitiy in a mouse model of colitis. [Abstract] Gastroenterology 1995; 108 (suppl):A944.
25. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994;106:533-9.
26. Grimm MC, Elsbury SK, Pavli P, et al. Interleukin 8: cells of origin in inflammatory bowel disease. Gut 1996;38:90-8.
27. McKenzie SJ, Doe WF, Buffinton GD. Selective recovery of colon epithelial cell GAPDH following in vitro exposure to oxidants. [Abstract] Gastroenterology 1997;112 (suppl): A1038.
28. Grisham MB, Gaginella TS, von Ritter C, et al. Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability. Inflammation 1990;14:531-42.
29. Yamada T, Volkmer C, Grisham MB. Antioxidant properties of 5-ASA: potential mechanism for its anti-inflammatory activity. Can J Gastroenterol 1990;4:295-302.
30. Grisham MB, Granger DN. 5-Aminosalicylic acid concentration in mucosal interstitium of cat small and large intestine. Dig Dis Sci 1989;34:573-8.
31. Jensen J, Cornett C, Olsen CE, et al. Identification of major degradation products of 5-aminosalicylic acid formed in aqueous solutions and in pharmaceuticals. Int J Pharm 1992;88:117-87.
32. Galaris D, Cadenas E, Hochstein P. Redox cycling of myoglobin and ascorbate: a potential protective mechanism against oxidative reperfusion injury in muscle. Arch Biochem Biophys 1989;273:497-504.
33. Galaris D, Cadenas E, Hochstein P. Glutathione-dependent reduction of peroxides during ferryl- and met-myoglobin interconversion: a potential protective mechanism in muscle. Free Radic Biol Med 1989;6:473-8.
34. Buffinton G, Cadenas E. Reduction of ferrylmyoglobin to metmyoglobin by quinonoid compounds. Chem Biol Interact 1988;66:233-50.
35. Buffinton G, Mira D, Galaris D, et al. Reduction of ferryl- and metmyoglobin to ferrous myoglobin by menadione- glutathione conjugate. Spectrophotometric studies under aerobic and anaerobic conditions. Chem Biol Interact 1988; 66:205-22.
36. Grisham MB, MacDermott RP, Deitch EA. Oxidant defence mechanisms in the human colon. Inflammation 1990;14:669-80.
37. von Ritter C, Grisham MB, Granger DN. Sulfasalazine metabolites and dapsone attenuate formyl-methionylleucyl-phenylalanine-induced mucosal injury in rat ileum. Gastroenterology 1989;96:811-16.
38. Grisham MB, Miles AM. Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions. Biochem Pharmacol 1994;47:1897-902.